Jinyu Bio-Technology Co

Jinyu Bio-Technology Co CROIC

The Cash Return on Invested Capital (CROIC) of Jinyu Bio-Technology Co (600201.SS) as of Oct 27, 2026 is 3.63 %. In the previous year, Cash Return on Invested Capital (CROIC) was 3.75 % — a change of -3.28% (lower).

CROIC

3.63 %

YoY

-3.28%

Last updated:

Cash Return on Invested Capital (CROIC) of Jinyu Bio-Technology Co is 2025 3.63 % . Cash Return on Invested Capital (CROIC) of Jinyu Bio-Technology Co was 2024 3.75 % . It decreases by -3.28% lower compared to the previous year.

The Jinyu Bio-Technology Co CROIC history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

CROIC
Date
CROIC
Jan 1, 2018
-2.44 CNY
Jan 1, 2019
2.09 CNY
Jan 1, 2020
9.28 CNY
Jan 1, 2021
3.04 CNY
Jan 1, 2022
3.04 CNY
Jan 1, 2023
2.64 CNY
Jan 1, 2024
3.75 CNY
Jan 1, 2025
3.63 CNY
The Jinyu Bio-Technology Co CROIC history
YEARCROICYoY
3.63 %-3.28%
3.75 %+42.13%
2.64 %-13.22%
3.04 %-0.05%
3.04 %-67.21%
9.28 %+344.30%
2.09 %-185.46%
-2.44 %-122.33%
10.94 %-34.02%
16.58 %+47.90%
11.21 %-51.63%
23.18 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Jinyu Bio-Technology Co Stock analysis

What does Jinyu Bio-Technology Co do? Jinyu Bio-Technology Co., Ltd. generates revenue by researching, developing, producing, and selling veterinary biological products, with a primary focus on veterinary vaccines. The company operates from its headquarters in Hohhot, Neimenggu, where it employs 1,618 full-time staff members to support these core activities. In addition to its main veterinary operations, the firm diversifies its income streams by engaging in textile processing, providing energy products, and offering property leasing and management activities. These supplementary services allow the company to serve various market segments beyond the veterinary sector. The business model relies on the direct sale of its veterinary vaccines and biological products to customers in the animal health industry. By integrating manufacturing with research and development, Jinyu Bio-Technology Co., Ltd. maintains control over its product quality and supply chain while expanding into related industrial and service areas. Jinyu Bio-Technology Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Jinyu Bio-Technology Co stock

Cash Return on Invested Capital (CROIC) of Jinyu Bio-Technology Co is 3.63 % in 2025.

Cash Return on Invested Capital (CROIC) of Jinyu Bio-Technology Co changed from 3.75 % to 3.63 %, representing a -3.28% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Cash Return on Invested Capital (CROIC) Jinyu Bio-Technology Co since 2006 – with annual values, charts, and detailed analysis.

CROIC measures the cash return generated on invested capital. Unlike ROIC, it uses free cash flow instead of accounting earnings, providing a purer profitability measure.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Cash Return on Invested Capital (CROIC)'s Jinyu Bio-Technology Co with sector peers and the industry average to assess whether it is attractive.

To evaluate Cash Return on Invested Capital (CROIC)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Cash Return on Invested Capital (CROIC).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Profitability — Jinyu Bio-Technology Co

ROEROAROCEROICAsset TurnoverInventory TurnoverReceivables TurnoverDays Sales OutstandingDays Inventory OutstandingDays Payable OutstandingCash Conversion CycleCROICGross Profit/AssetsFixed Asset TurnoverEquity TurnoverWorking Capital TurnoverPayables TurnoverCapital IntensityReceivables/RevenueInventory/RevenueEBIT/Assets

All Key Metrics — Jinyu Bio-Technology Co